{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:14:09Z","timestamp":1788783249063,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14CIII\/00005"],"award-info":[{"award-number":["PI14CIII\/00005"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17CIII\/00013"],"award-info":[{"award-number":["PI17CIII\/00013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Oncohematolog\u00eda Infantil, Asociaci\u00f3n Pablo Ugarte, and AFANION."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41417-020-0184-9","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:07:28Z","timestamp":1590534448000},"page":"64-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses"],"prefix":"10.1038","volume":"28","author":[{"given":"Miguel \u00c1ngel","family":"Rodr\u00edguez-Milla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4532-7667","authenticated-orcid":false,"given":"Alvaro","family":"Morales-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-3968","authenticated-orcid":false,"given":"Ana Judith","family":"Peris\u00e9-Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cejalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-1640","authenticated-orcid":false,"given":"Javier","family":"Garc\u00eda-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"184_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s40259-016-0189-y","volume":"30","author":"K Garnock-Jones","year":"2016","unstructured":"Garnock-Jones K. Talimogene Laherparepvec: a review in unresectable metastatic melanoma. BioDrugs. 2016;30:461\u20138.","journal-title":"BioDrugs"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/cgt.2010.4","volume":"17","author":"J Garc\u00eda-Castro","year":"2010","unstructured":"Garc\u00eda-Castro J, Alemany R, Cascall\u00f3 M, Mart\u00ednez-Quintanilla J, Arriero MM, Lassaletta A, et al. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study. Cancer Gene Ther. 2010;17:476\u201383.","journal-title":"Cancer Gene Ther"},{"key":"184_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.canlet.2015.11.036","volume":"371","author":"GJ Melen","year":"2016","unstructured":"Melen GJ, Franco-Luzon L, Ruano D, Gonzalez-Murillo A, Alfranca A, Casco F, et al. Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells. Cancer Lett. 2016;371:161\u201370.","journal-title":"Cancer Lett"},{"key":"184_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ymthe.2020.01.019","volume":"28","author":"D Ruano","year":"2020","unstructured":"Ruano D, Lopez-Martin JA, Moreno L, Lassaletta A, Bautista F, Andion M, et al. First-in-human, first-in-child trial of autologous MSCs carrying the oncolytic virus Icovir-5 in patients with advanced tumors. Mol Ther. 2020;28:1033\u201342.","journal-title":"Mol Ther"},{"key":"184_CR5","doi-asserted-by":"publisher","first-page":"45415","DOI":"10.18632\/oncotarget.17557","volume":"8","author":"E Rinc\u00f3n","year":"2017","unstructured":"Rinc\u00f3n E, Cejalvo T, Kanojia D, Alfranca A, Rodr\u00edguez-Milla MA, Gil Hoyos RA, et al. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model. Oncotarget. 2017;8:45415\u201331.","journal-title":"Oncotarget"},{"key":"184_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00262-018-2220-2","volume":"67","author":"A Morales-Molina","year":"2018","unstructured":"Morales-Molina A, Gambera S, Cejalvo T, Moreno R, Rodriguez-Milla MA, Perise-Barrios AJ, et al. Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice. Cancer Immunol Immunother. 2018;67:1589\u2013602.","journal-title":"Cancer Immunol Immunother"},{"key":"184_CR7","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1158\/0008-5472.CAN-17-3754","volume":"78","author":"T Cejalvo","year":"2018","unstructured":"Cejalvo T, Peris\u00e9-Barrios AJ, Portillo Id, Laborda E, Rodriguez-Milla M, Cubillo I, et al. Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy. Cancer Res. 2018;78:4891\u2013901.","journal-title":"Cancer Res"},{"key":"184_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2273","volume":"8","author":"M Paoloni","year":"2008","unstructured":"Paoloni M, Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer. 2008;8:147\u201356.","journal-title":"Nat Rev Cancer"},{"key":"184_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.addr.2007.06.007","volume":"59","author":"PC Leopold","year":"2007","unstructured":"Leopold PC. RG. Intracellular trafficking of adenovirus: many means to many ends. Adv Drug Deliv Rev. 2007;59:810\u201321.","journal-title":"Adv Drug Deliv Rev"},{"key":"184_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1556\/EuJMI.1.2011.4.3","volume":"1","author":"G Fejer","year":"2011","unstructured":"Fejer G, Freudenberg M, Greber U, Gyory I. Adenovirus-triggered innate signalling pathways. Eur Jl Microbiol Immunol. 2011;1:279\u201388.","journal-title":"Eur Jl Microbiol Immunol"},{"key":"184_CR11","doi-asserted-by":"publisher","first-page":"190012","DOI":"10.1098\/rsob.190012","volume":"9","author":"J Flatt","year":"2019","unstructured":"Flatt J, Butcher S. Adenovirus flow in host cell networks. Open Biol. 2019;9:190012.","journal-title":"Open Biol"},{"key":"184_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.coviro.2016.08.017","volume":"21","author":"S Atasheva","year":"2016","unstructured":"Atasheva S, Shayakhmetov D. Adenovirus sensing by the immune system. Curr Opin Virol. 2016;21:109\u201313.","journal-title":"Curr Opin Virol"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1128\/JVI.01530-06","volume":"81","author":"M Perreau","year":"2007","unstructured":"Perreau M, Mennechet F, Serratrice N, Glasgow J, Curiel D, Wodrich H, et al. Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy. J Virol. 2007;81:3272\u201384.","journal-title":"J Virol"},{"key":"184_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069808","volume":"8","author":"S Piersanti","year":"2013","unstructured":"Piersanti S, Astrologo L, Licursi V, Costa R, Roncaglia E, Gennetier A, et al. Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles. PLoS ONE. 2013;8:e69808.","journal-title":"PLoS ONE"},{"key":"184_CR15","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/sj.mt.6300239","volume":"15","author":"M Cascallo","year":"2007","unstructured":"Cascallo M, Alonso M, Rojas J, Perez-Gimenez A, Fueyo J, Alemany R. Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway. Mol Ther. 2007;15:1607\u201315.","journal-title":"Mol Ther"},{"key":"184_CR16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/mt.2014.7","volume":"22","author":"E Laborda","year":"2014","unstructured":"Laborda E, Puig-Saus C, Rodriguez-Garcia A, Moreno R, Cascallo M, Pastor J, et al. A pRb-responsive, RGD-modified, and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncology. Mol Ther. 2014;22:986\u201398.","journal-title":"Mol Ther"},{"key":"184_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jviromet.2009.09.010","volume":"163","author":"MM Segura","year":"2010","unstructured":"Segura MM, Monfar M, Puig M, Mennechet F, Ibanes S, Chillon M. A real-time PCR assay for quantification of canine adenoviral vectors. J Virol Methods. 2010;163:129\u201336.","journal-title":"J Virol Methods"},{"key":"184_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/mt.2013.19","volume":"21","author":"A Wilson","year":"2013","unstructured":"Wilson A, Kwok L, Porter E, Payne J, McElroy G, Ohle S, et al. Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages. Mol Ther. 2013;21:825\u201333.","journal-title":"Mol Ther"},{"issue":"D1","key":"184_CR19","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u2013d13.","journal-title":"Nucleic Acids Res"},{"key":"184_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1126\/science.1226625","volume":"9","author":"K Doronin","year":"2012","unstructured":"Doronin K, Flatt JW, Di Paolo NC, Khare R, Kalyuzhniy O, Acchione M, et al. Coagulation factor X activates innate immunity to human species C adenovirus. Science. 2012;9:795\u20138.","journal-title":"Science"},{"key":"184_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1476-5829.2011.00309.x","volume":"11","author":"J McCleese","year":"2013","unstructured":"McCleese J, Bear M, Kulp S, Mazcko C, Khanna C, London C. Met interacts with EGFR and Ron in canine osteosarcoma. Vet Comp Oncol. 2013;11:124\u201339.","journal-title":"Vet Comp Oncol"},{"key":"184_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042662","volume":"7","author":"O Treacy","year":"2012","unstructured":"Treacy O, Ryan A, Heinzl T, O\u2019Flynn L, Cregg M, Wilk M, et al. Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. PLoS ONE. 2012;7:e42662.","journal-title":"PLoS ONE"},{"key":"184_CR23","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1128\/JVI.02199-06","volume":"81","author":"G Bowick","year":"2007","unstructured":"Bowick G, Fennewald S, Scott E, Zhang L, Elsom B, Aronson J, et al. Identification of differentially activated cell-signaling networks associated with Pichinde virus pathogenesis by using systems kinomics. J Virol. 2007;81:1923\u201333.","journal-title":"J Virol"},{"key":"184_CR24","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1099\/vir.0.19771-0","volume":"85","author":"S Cooray","year":"2004","unstructured":"Cooray S. The pivotal role of phosphatidylinositol 3-kinase\u2013Akt signal transduction in virus survival. J Gen Viro. 2004;85:1065\u201376.","journal-title":"J Gen Viro"},{"key":"184_CR25","doi-asserted-by":"publisher","first-page":"12332","DOI":"10.1128\/JVI.79.19.12332-12341.2005","volume":"79","author":"MS Rajala","year":"2005","unstructured":"Rajala MS, Rajala RV, Astley RA, Butt AL, Chodosh J. Corneal cell survival in adenovirus type 19 infection requires phosphoinositide 3-kinase\/Akt activation. J Virol. 2005;79:12332\u201341.","journal-title":"J Virol"},{"key":"184_CR26","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1038\/onc.2014.452","volume":"34","author":"S Klein","year":"2015","unstructured":"Klein S, Piya S, Lu Z, Xia Y, Alonso M, White E, et al. C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy. Oncogene. 2015;34:5295\u2013301.","journal-title":"Oncogene"},{"key":"184_CR27","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1128\/JVI.72.3.2055-2061.1998","volume":"72","author":"E Li","year":"1998","unstructured":"Li E, Stupack D, Klemke R, Cheresh DA, Nemerow GR. Adenovirus endocytosis via \u03b1 v integrins requires phosphoinositide-3-OH kinase. J Virol. 1998;72:2055\u201361.","journal-title":"J Virol"},{"key":"184_CR28","doi-asserted-by":"publisher","first-page":"10639","DOI":"10.1128\/JVI.74.22.10639-10649.2000","volume":"74","author":"C Soudais","year":"2000","unstructured":"Soudais C, Boutin S, Hong Sea. Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J Virol. 2000;74:10639\u201349.","journal-title":"J Virol"},{"key":"184_CR29","doi-asserted-by":"publisher","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","volume":"72","author":"I Dmitriev","year":"1998","unstructured":"Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol. 1998;72:9706\u201313.","journal-title":"J Virol"},{"key":"184_CR30","doi-asserted-by":"publisher","first-page":"33704","DOI":"10.1074\/jbc.M605316200","volume":"281","author":"E Seiradake","year":"2006","unstructured":"Seiradake E, Lortat-Jacob H, Billet O, Kremer EJ, Cusack S. Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor. J Biol Chem. 2006;281:33704\u201316.","journal-title":"J Biol Chem"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41417-020-0184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41417-020-0184-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41417-020-0184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:58Z","timestamp":1684617058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-0184-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1038\/s41417-020-0184-9","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}